Inventor · disambiguated record
Roy H. Larsen
Also filed as: LARSEN ROY · LARSEN ROY H · LARSEN ROY HARTVIG
20 granted patents·20 pending applications·180 citations·filing 2000–2025
94Inventor score
Top patents by PatentIndex Score
40 records- 0196US12249437B2Production of highly purified 212PBSciencons AS·Filed 2024·Granted Mar 11, 2025·3 cites·38 claims
- 0296US12125603B2Production of highly purified 212PbSciencons AS·Filed 2020·Granted Oct 22, 2024·4 cites·20 claims
- 0395US10434198B2Radiopharmaceutical solutions with advantageous propertiesSciencons AS·Filed 2016·Granted Oct 8, 2019·10 cites·14 claims
- 0491US9433690B1Radiopharmaceutical solutions with advantageous propertiesSciencons AS·Filed 2015·Granted Sep 6, 2016·5 cites·8 claims
- 0590US6635234B1Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioningANTICANCER THERAPEUTIC INV SA·Filed 2000·Granted Oct 21, 2003·66 cites·20 claims
- 0689US12394533B2Production of highly purified 212PBSciencons AS·Filed 2024·Granted Aug 19, 2025·0 cites·30 claims
- 0789US2025336557A1Production of highly purified 212pbSciencons AS·Filed 2025·Application pending·0 cites
- 0889US2025336558A1Production of highly purified 212pbSciencons AS·Filed 2025·Application pending·0 cites
- 0989US2025336559A1Production of highly purified 212pbSciencons AS·Filed 2025·Application pending·0 cites
- 1088US10377778B2Lead and thorium compoundsSciencons AS·Filed 2018·Granted Aug 13, 2019·2 cites·13 claims
- 1188US2025210212A1Production Of Highly Purified 212PBSciencons AS·Filed 2024·Application pending·0 cites
- 1288US2025201434A1Production of Highly Purified 212PBSciencons AS·Filed 2024·Application pending·0 cites
- 1388US2025210211A1Production of highly purified 212pbSciencons AS·Filed 2024·Application pending·0 cites
- 1487US6740304B2Receptor binding conjugatesANTICANCER THERAPEUTIC INV SA·Filed 2000·Granted May 25, 2004·16 cites·10 claims
- 1584US9782500B2Monoclonal antibody and derivativesONCOINVENT AS·Filed 2014·Granted Oct 10, 2017·14 cites·7 claims
- 1684US6592843B2Radioactive therapeutic liposomesANTICANCER THERAPEUTIC INV SA·Filed 2001·Granted Jul 15, 2003·25 cites·35 claims
- 1782US12406776B2Production of highly purified 212PbSciencons AS·Filed 2025·Granted Sep 2, 2025·0 cites·19 claims
- 1882US12297218B2Complex comprising a PSMA-targeting compound linked to a lead or thorium radionuclideSciencons AS·Filed 2023·Granted May 13, 2025·0 cites·20 claims
- 1979US8142758B2Alpha-emitting hydroxyapatite particlesLARSEN ROY H·Filed 2005·Granted Mar 27, 2012·13 cites·11 claims
- 2077US7056275B2RadiotherapyALGETA AS·Filed 2001·Granted Jun 6, 2006·16 cites·20 claims
- 2177US2024247011A1Complex comprising a psma-targeting compound linked to a lead or thorium radionuclideSciencons AS·Filed 2024·Application pending·0 cites
- 2273US9539346B1Radiotherapeutic particles and suspensionsONCOINVENT AS·Filed 2015·Granted Jan 10, 2017·4 cites·11 claims
- 2371US7335154B2RadiotherapyALGETA AS·Filed 2006·Granted Feb 26, 2008·2 cites·12 claims
- 2462US2015258223A1Receptor binding conjugatesALGETA ASA·Filed 2014·Application pending·0 cites
- 2561US2014235924A1Method of radiotherapyALGETA ASA·Filed 2014·Application pending·0 cites
- 2661US2025099631A1Complexes for cancer treatment and imagingSciencons AS·Filed 2023·Application pending·0 cites
- 2761US2004184990A1Receptor binding conjugatesFiled 2004·Application pending·0 cites
- 2851US11306038B2Preparation of 212Pb labeled monoclonal antibodiesSciencons AS·Filed 2017·Granted Apr 19, 2022·0 cites·15 claims
- 2951US10646599B2Method for upregulating antigen expressionNORDIC NANOVECTOR ASA·Filed 2018·Granted May 12, 2020·0 cites·5 claims
- 3051US2004009955A1Method of prophylaxisFiled 2003·Application pending·0 cites
- 3149US2023372554A1Size controlled radiolabelled particlesONCOINVENT AS·Filed 2021·Application pending·0 cites
- 3248US2003206857A1Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioningFiled 2003·Application pending·0 cites
- 3344US9358309B2Radioimunoconjugates and uses thereofNORDIC NANOVECTOR AS·Filed 2013·Granted Jun 7, 2016·0 cites·11 claims
- 3443US2008193374A1Liposomes Enclosing a Radionuclide and a Cytotoxic Agent for Combination TherapyLARSEN ROY·Filed 2005·Application pending·0 cites
- 3542US8628749B2Radioimmunoconjugates and uses thereofLARSEN ROY H·Filed 2011·Granted Jan 14, 2014·0 cites·12 claims
- 3640US2004208821A1Method of radiotherapyFiled 2003·Application pending·0 cites
- 3739US2018194852A1Chimeric therapeutic anti - cd37 antibodie hh1NORDIC NANOVECTOR ASA·Filed 2017·Application pending·0 cites
- 3838US2014348745A1Chimeric therapeutic anti - cd37 antibodie hh1NORDIC NANOVECTOR AS·Filed 2012·Application pending·0 cites
- 3937US2016101199A1Method for upregulating antigen expressionNORDIC NANOVECTOR AS·Filed 2014·Application pending·0 cites
- 4037US2006228297A1Thorium-227 for use in radiotherapy of soft tissue diseaseLARSEN ROY·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roy H. Larsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →